首站-论文投稿智能助手
典型文献
Non-apoptotic cell death-based cancer therapy:Molecular mechanism,pharmacological modulators,and nanomedicine
文献摘要:
As an emerging cancer therapeutic target,non-apoptotic cell death such as ferroptosis,ne-croptosis and pyroptosis,etc.,has revealed significant potential in cancer treatment for bypassing apoptosis to enhance the undermined therapeutic efficacy triggered by apoptosis resistance.A variety of anticancer drugs,synthesized compounds and natural products have been proven recently to induce non-apoptotic cell death and exhibit excellent anti-tumor effects.Moreover,the convergence of nanotech-nology with functional materials and biomedicine science has provided tremendous opportunities to construct non-apoptotic cell death-based nanomedicine for innovative cancer therapy.Nanocarriers are not only employed in targeted delivery of non-apoptotic inducers,but also used as therapeutic compo-nents to induce non-apoptotic cell death to achieve efficient tumor treatment.This review first introduces the main characteristics,the mechanism and various pharmacological modulators of different non-apoptotic cell death forms,including ferroptosis,necroptosis,pyroptosis,autophagy,paraptosis,lysosomal-dependent cell death,and oncosis.Second,we comprehensively review the latest progresses of nanomedicine that induces various forms of non-apoptotic cell death and focus on the nanomedicine targeting different pathways and components.Furthermore,the combination therapies of non-apoptotic cell death with photothermal therapy,photodynamic therapy,immunotherapy and other modalities are summarized.Finally,the challenges and future perspectives in this regard are also discussed.
文献关键词:
作者姓名:
Xuan Wang;Peng Hua;Chengwei He;Meiwan Chen
作者机构:
State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,Macau,SAR 999078,China
引用格式:
[1]Xuan Wang;Peng Hua;Chengwei He;Meiwan Chen-.Non-apoptotic cell death-based cancer therapy:Molecular mechanism,pharmacological modulators,and nanomedicine)[J].药学学报(英文版),2022(09):3567-3593
A类:
croptosis,Nanocarriers,paraptosis,oncosis
B类:
Non,apoptotic,death,Molecular,mechanism,pharmacological,modulators,nanomedicine,emerging,therapeutic,such,ferroptosis,pyroptosis,etc,has,revealed,significant,potential,treatment,bypassing,apoptosis,enhance,undermined,efficacy,triggered,resistance,variety,anticancer,drugs,synthesized,compounds,natural,products,have,been,proven,recently,exhibit,excellent,tumor,effects,Moreover,convergence,nanotech,nology,functional,materials,biomedicine,science,provided,tremendous,opportunities,construct,innovative,are,only,employed,targeted,delivery,inducers,but,also,used,achieve,efficient,This,review,first,introduces,main,characteristics,various,different,forms,including,necroptosis,autophagy,lysosomal,dependent,Second,we,comprehensively,latest,progresses,that,induces,focus,targeting,pathways,components,Furthermore,combination,therapies,photothermal,photodynamic,immunotherapy,modalities,summarized,Finally,challenges,future,perspectives,this,regard,discussed
AB值:
0.529884
相似文献
The structure of erastin-bound xCT-4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis
Renhong Yan;Enjun Xie;Yaning Li;Jin Li;Yuanyuan Zhang;Ximin Chi;Xueping Hu;Lei Xu;Tingjun Hou;Brent R.Stockwell;Junxia Mini;Qiang Zhou;Fudi Wang-Westlake Laboratory of Life Sciences and Biomedicine,Key Laboratory of Structural Biology of Zhejiang Province,Institute of Biology,Westlake Institute for Advanced Study,School of Life Sciences,Westlake University,Hangzhou,Zhejiang,China;Department of Biochemistry,School of Medicine,Southern University of Science and Technology,Shenzhen,Guangdong,China;The First Affiliated Hospital,The Fourth Affiliated Hospital,School of Public Health,Institute of Translational Medicine,Cancer Center,State Key Laboratory of Experimental Hematology,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;The First Affiliated Hospital,The Second Affiliated Hospital,Basic Medical Sciences,School of Public Health,Hengyang Medical School,University of South China,Hengyang,Hunan,China;Beijing Advanced Innovation Center for Structural Biology,Tsinghua-Peking Joint Center for Life Sciences,School of Life Sciences,Tsinghua University,Beijing,China;Hangzhou Institute of Innovative Medicine,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou,Zhejiang,China;Institute of Bioinformatics and Medical Engineering,Jiangsu University of Technology,Changzhou,Jiangsu,China;Department of Biological Sciences and Department of Chemistry,Columbia University,New York,NY,USA
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-cai Xu;Li Yang;Pei-quan Zhang;Ding Yan;Qian Xue;Qing-tian Huang;Xiao-fen Li;Ya-li Hao;Dao-lin Tang;Q.Ping Dou;Xin Chen;Jin-bao Liu-Affliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;The Department of Physiology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550003,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。